Akebia Therapeutics, Inc. - Common Stock (AKBA) — AI analysis & news
Akebia Therapeutics, Inc. - Common Stock (AKBA) stock: 11 recent news items, slightly positive aggregate sentiment, AI analysis and market context on…
Current sentiment read
Across the last 11 indexed AKBA stories, aggregate finance-aware sentiment is slightly positive (+0.21 on a -1 to +1 scale).
Latest AKBA news
- Guggenheim initiates Kazia Therapeutics stock with buy rating By Investing.com - Investing.com India · Investing.com India
- Why is Kazia Therapeutics stock rallying today? - Investing.com · Investing.com
- Leerink initiates Kazia Therapeutics stock with $30 target - Investing.com · Investing.com
- Kazia Therapeutics stock falls on $40M public offering - Investing.com · Investing.com
- Why is Kazia Therapeutics stock rallying today? By Investing.com - Investing.com UK · Investing.com UK
- Leerink initiates Kazia Therapeutics stock with $30 target By Investing.com - Investing.com UK · Investing.com UK
- Rakovina Therapeutics Inc. (RKV.V) Stock Price, News, Quote & History - Yahoo! Finance Canada · Yahoo! Finance Canada
- Why is Egetis Therapeutics stock surging today? - Investing.com India · Investing.com India
- Why is Egetis Therapeutics stock surging today? - Investing.com · Investing.com
- Why is Egetis Therapeutics stock surging today? By Investing.com - Investing.com UK · Investing.com UK
- Bank of New York Mellon Corporation (BNY) Lost A Depositary Mandate · Simply Wall St.
FAQ
What is the current sentiment for AKBA stock?
Aggregate finance-aware sentiment across the last 11 indexed AKBA news stories is slightly positive (+0.21 on a -1 to +1 scale).